Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20671417rdf:typepubmed:Citationlld:pubmed
pubmed-article:20671417lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0473169lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0021665lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0289313lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0439858lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0205318lld:lifeskim
pubmed-article:20671417lifeskim:mentionsumls-concept:C0418981lld:lifeskim
pubmed-article:20671417pubmed:issue2lld:pubmed
pubmed-article:20671417pubmed:dateCreated2011-4-19lld:pubmed
pubmed-article:20671417pubmed:abstractTextCurrent therapies for acromegaly are unsatisfactory for some patients. High-dose thiazolidinediones have been reported to reduce serum GH levels in animal models of acromegaly. The objective of the study was to evaluate the effect of increasing doses of rosiglitazone on serum GH and IGF-I concentrations in acromegalic patients.lld:pubmed
pubmed-article:20671417pubmed:languageenglld:pubmed
pubmed-article:20671417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:citationSubsetIMlld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20671417pubmed:statusMEDLINElld:pubmed
pubmed-article:20671417pubmed:monthFeblld:pubmed
pubmed-article:20671417pubmed:issn1720-8386lld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:RossiGGlld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:LombardiMMlld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:MartinoEElld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:UrbaniCClld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:BogazziFFlld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:RaggiFFlld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:SardellaCClld:pubmed
pubmed-article:20671417pubmed:authorpubmed-author:CosciCClld:pubmed
pubmed-article:20671417pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20671417pubmed:volume34lld:pubmed
pubmed-article:20671417pubmed:ownerNLMlld:pubmed
pubmed-article:20671417pubmed:authorsCompleteYlld:pubmed
pubmed-article:20671417pubmed:paginatione43-51lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:meshHeadingpubmed-meshheading:20671417...lld:pubmed
pubmed-article:20671417pubmed:year2011lld:pubmed
pubmed-article:20671417pubmed:articleTitleEffect of rosiglitazone on serum IGF-I concentrations in uncontrolled acromegalic patients under conventional medical therapy: results from a pilot phase 2 study.lld:pubmed
pubmed-article:20671417pubmed:affiliationDepartment of Endocrinology and Metabolism, University of Pisa, Via Paradisa 2, 56124 Pisa, Italy. fausto.bogazzi@med.unipi.itlld:pubmed
pubmed-article:20671417pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20671417pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20671417pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
entrez-gene:3479entrezgene:pubmedpubmed-article:20671417lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20671417lld:entrezgene